Posted on 4/28/20
Merck Announces First-Quarter 2020 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2020.“In this challenging . . .
Posted on 4/28/20
Pfizer Reports First-Quarter 2020 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain . . .
Posted on 4/28/20
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
NEW HAVEN, Conn., April 28, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 4/28/20
Biohaven Enters Into Agreement With Genpharm
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT . . .
Posted on 4/28/20
AMC Health Expands Partnership with Geisinger Health
AMC Health, the leading provider in telehealth and remote patient monitoring (RPM) technology, announced its expanded relationship with long-term client Geisinger, utilizing AMC's telehealth capabilities to . . .
Posted on 4/27/20
States Where Social Distancing Is Most Difficult – WalletHub Study
Social distancing is the most effective way to prevent the spread of coronavirus, as the main way the virus spreads is through close contact between people. . . .
Posted on 4/27/20
70% of Investors Believe a COVID-19 Recession Will Be Worse Than 2008 -- But Here's the Silver Lining
COVID-19 has had a tremendous effect on millions of Americans' finances. With approximately 22 million U.S. adults filing for unemployment benefits over the last month and . . .
Posted on 4/27/20
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
Investors watched in horror as shares of the world's largest biopharmaceutical companies tumbled during the first quarter of 2020. However, thanks to some swift action when . . .
Posted on 4/27/20
Teladoc Earnings Preview: What to Watch
Teladoc Health (NYSE:TDOC), the leader in virtual healthcare, is slated to report its first quarter 2020 results after the market closes on Wednesday, April 29.Investors already . . .
Posted on 4/26/20
Cyclacel Closes $20M Public Offering
BERKELEY HEIGHTS, N.J., April 24, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 4/26/20
Caladrius Biosciences Announces $5M Registered Direct Offering
BASKING RIDGE, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 4/26/20
AzurRx BioPharma Issues Letter to Shareholders
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today . . .
Posted on 4/26/20
Actinium Pharmaceuticals Closes $31.6M Public Offering
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced the closing of the Company's previously announced underwritten public offering of 210,833,334 shares of common stock (or common . . .
Posted on 4/24/20
Johnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 Vaccine
Johnson & Johnson (NYSE:JNJ) signed a contract to pay Emergent BioSolutions (NYSE:EBS) $135 million to help manufacture its vaccine to treat COVID-19, the disease caused by . . .
Posted on 4/24/20
Pfizer Declares $0.38 Dividend
Pfizer (NYSE:PFE) declares $0.38/share quarterly dividend, in line with previous.Forward yield 4.11%Payable June 5; for shareholders of record May 8; ex-div May 7.READ FULL ARTICLE HERE
Posted on 4/24/20
Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works
When Pfizer (NYSE:PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared . . .
Posted on 4/24/20
Better Buy: Amgen vs. Johnson & Johnson
If you're the kind of investor who likes to go big or go home, Amgen (NASDAQ:AMGN) and Johnson & Johnson (NYSE:JNJ) might be right up your . . .
Posted on 4/24/20
Here's Why Immunomedics Shares Are Skyrocketing Today
What happenedAfter the Food and Drug Administration approved the company's advanced breast cancer drug Trodelvy on Wednesday, the stock of Immunomedics (NASDAQ:IMMU) surged 22.9% as of . . .
Posted on 4/24/20
Click Therapeutics Launches New Brand Identity and Redesigned Website
NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc., a leader in Digital Therapeutics™ solutions as prescription medical treatments, today unveiled a new brand identity, website, and logo which reflect . . .
Posted on 4/24/20
Immunic Prices $15 Million Financing
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that . . .
Posted on 4/23/20
Chardan Healthcare Acquisition 2 Corp. Prices $85M IPO
Chardan Healthcare Acquisition 2 Corp. (NYSE American: CHAQ.U) announced today that it priced its initial public offering of 8,500,000 units at $10.00 per unit. The units . . .
Posted on 4/23/20
Celsion Receives $2.5 Million Funding
Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced it has received $1.82 million of net cash proceeds from the sale of approximately $1.9 . . .
Posted on 4/23/20
Why You're Smart to Buy Bristol Myers Squibb
Some decisions that we make lead to second-guessing ourselves. We wonder whether or not we made the best choice. But other decisions are ones that we . . .
Posted on 4/23/20
Johnson & Johnson: The Defensive Stock To Own Through COVID-19
SummaryJohnson & Johnson reports an impressive Q1 and hikes the dividend.The company's diversified profile makes it particularly resilient, even through a pandemic.JNJ's COVID-19 vaccine development lags . . .
Posted on 4/23/20
Will Johnson & Johnson's Coronavirus Vaccine Dominate the Market?
Whether from niche vaccine developers or well-established pharmaceutical giants, over 70 potential coronavirus vaccines are currently undergoing development. Johnson & Johnson (NYSE:JNJ) was one of the . . .
New York
